BM stromal cells ameliorate experimental autoimmune myasthenia gravis by altering the balance of Th cells through the secretion of IDO. (Q51770946)

12 April 2018

title

BM stromal cells ameliorate experimental autoimmune myasthenia gravis by altering the balance of Th cells through the secretion of IDO. (English)

1 reference

12 April 2018

0 references

Qing-fei Kong

1

1 reference

12 April 2018

Bo Sun

2

1 reference

12 April 2018

Guang-you Wang

3

1 reference

12 April 2018

Dong-xu Zhai

4

1 reference

12 April 2018

Li-li Mu

5

1 reference

12 April 2018

Dan-dan Wang

6

1 reference

12 April 2018

Jing-hua Wang

7

1 reference

12 April 2018

Rui Li

8

1 reference

12 April 2018

Hu-lun Li

9

1 reference

12 April 2018

language of work or name

English

0 references

publication date

1 March 2009

1 reference

12 April 2018

European Journal of Immunology

published in

1 reference

12 April 2018

volume

39

1 reference

12 April 2018

issue

3

1 reference

12 April 2018

page(s)

800-809

1 reference

12 April 2018

Multilineage potential of adult human mesenchymal stem cells

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Bone marrow stromal cells generate muscle cells and repair muscle degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Human mesenchymal stem cells modulate B-cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Human mesenchymal stem cells modulate allogeneic immune cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Immunoregulation in experimental autoimmune myasthenia gravis--about T cells, antibodies, and endplates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Experimental autoimmune myasthenia: A model of myasthenia gravis in rats and guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Interferon-gamma-modified dendritic cells suppress B cell function and ameliorate the development of experimental autoimmune myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Indoleamine 2,3-dioxygenase in lung dendritic cells promotes Th2 responses and allergic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Functional yet balanced reactivity to Candida albicans requires TRIF, MyD88, and IDO-dependent inhibition of Rorc.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

T Cells and Cytokines in the Pathogenesis of Acquired Myasthenia Gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Myasthenia gravis-like syndrome induced by expression of interferon gamma in the neuromuscular junction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Interferon gamma (IFN-gamma) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Th17 cell induction and immune regulatory effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Interleukin-17: a new paradigm in inflammation, autoimmunity, and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

C57BL/6 mice genetically deficient in IL-12/IL-23 and IFN-gamma are susceptible to experimental autoimmune myasthenia gravis, suggesting a pathogenic role of non-Th1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Mechanisms of T regulatory cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Resistance to experimental autoimmune myasthenia gravis in IL-6-deficient mice is associated with reduced germinal center formation and C3 production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Breakdown of tolerance to a self-peptide of acetylcholine receptor alpha-subunit induces experimental myasthenia gravis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

In vitro preprogramming of marrow stromal cells for myocardial regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

7 January 2021

Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

7 January 2021

CD4+ T and B cells cooperate in the immunoregulation of Experimental Autoimmune Myasthenia Gravis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

7 January 2021

IL-12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody-mediated disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

7 January 2021

Cooperation of Invariant NKT Cells and CD4+CD25+ T Regulatory Cells in the Prevention of Autoimmune Myasthenia

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

7 January 2021

IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

7 January 2021

IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838729

7 January 2021

Identifiers

DOI

10.1002/EJI.200838729

1 reference

12 April 2018

1 reference

12 April 2018